StrideBio Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- StrideBio's estimated annual revenue is currently $9.5M per year.
- StrideBio's estimated revenue per employee is $155,000
- StrideBio has 61 Employees.
- StrideBio grew their employee count by 74% last year.
- StrideBio currently has 1 job openings.
What Is StrideBio?
StrideBio is a product-driven, fully integrated gene therapy company focused on creating and developing innovative genetic medicines with life-changing or curative potential for patients with devastating conditions, including monogenic rare disease and beyond. We leverage our proprietary structure-inspired adeno-associated virus (AAV) vector engineering platform to create unique and differentiated vectors that improve upon naturally occurring AAV serotypes to overcome current limitations of first-generation gene therapies. Improved characteristics of StrideBioￃﾢ￢ﾂﾬ￢ﾄﾢs AAV vectors include evasion of pre-existing neutralizing antibodies, tissue targeting and de-targeting, enhanced potency, and manufacturability at scale. Combined with our gene construct design expertise and in-house manufacturing capabilities, StrideBio is positioned to generate best-in-class genetic medicines that allow more patients to benefit with maximum efficiency. StrideBio is based in a state-of-the-art 24,000-square-foot facility in Research Triangle Park, N.C, which houses our offices, research labs and in-house AAV manufacturing facilities.keywords:N/A